Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies

Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer

(2017) Philip J. Saylor et al.   Journal of the National Comprehensive Cancer Network

Androgen Deprivation Therapy and Cardiovascular Risk in Chinese Patients with Nonmetastatic Carcinoma of Prostate

(2014) Gang Huang et al.   Journal of Oncology

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies

(2013) Shimiao Zhu et al.   BMC CANCER

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

(2013) Ruth E Langley et al.   LANCET ONCOLOGY

Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites

(2013) Da-Quan Liu   WORLD JOURNAL OF GASTROENTEROLOGY

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversy

(2012) Vincenza Conteduca et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer

(2011) Elisa Martín-Merino et al.   DRUG SAFETY

Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

(2011) Mieke Van Hemelrijck et al.   EUROPEAN UROLOGY

Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden

(2011) David Robinson et al.   INTERNATIONAL JOURNAL OF CANCER

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

(2011) Paul L. Nguyen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Androgen Deprivation Therapy and Cardiovascular Risk

(2011) Sanoj Punnen et al.   JOURNAL OF CLINICAL ONCOLOGY

Population-Based Study of Cardiovascular Mortality Among Patients With Prostate Cancer Treated With Radical External Beam Radiation Therapy With and Without Adjuvant Androgen Deprivation Therapy at the British Columbia Cancer Agency

(2010) Julian Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden

(2010) Mieke Van Hemelrijck et al.   JOURNAL OF CLINICAL ONCOLOGY

The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease

(2009) A. M. Traish et al.   JOURNAL OF ANDROLOGY

Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

(2009) Shabbir M.H. Alibhai et al.   JOURNAL OF CLINICAL ONCOLOGY

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

(2009) N. L. Keating et al.   JNCI-Journal of the National Cancer Institute

Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02

(2008) Jason A. Efstathiou et al.   EUROPEAN UROLOGY

Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)

(2008) Fritz H. Schröder et al.   EUROPEAN UROLOGY

Low Serum Testosterone and Mortality in Older Men

(2007) Gail A. Laughlin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM